CEACAM5 and breast carcinoma: Serum CA15-3, CEA, c-Myc, p53 and Hsp27 have been observed to increase in breast cancer, CA15-3 in colorectal cancers, p53 in lung cancer and colon cancer, and Hsp27 in ovarian cancer [42–52].